CONCENTRATIONS	6 Months Ended
Jun. 30, 2021
CONCENTRATIONS
CONCENTRATIONS	(8) CONCENTRATIONS For the three months ended June 30, 2021, the Company sourced approximately 31% of the supplies for its electrotherapy products from one significant vendor (defined as supplying at least 10%). For the same period in 2020, the Company sourced approximately 36% of the supplies from one significant vendor. For the six months ended June 30, 2021, the Company sourced approximately 35% of supplies for its electrotherapy products from two significant vendors. For the same period in 2020 the company sourced approximately 34% of supplies from one significant vendor. Management believes that its relationships with suppliers are good; however, if the relationships were to be replaced, there may be a short-term disruption to operations, a period of time in which products may not be available and additional expenses may be incurred. The Company had receivables from two third-party payers at June 30, 2021 that made up approximately 37% of the net accounts receivable balance. At December 31, 2020, the Company had receivables from one third-party payer that made up approximately 26% of the net accounts receivable balance.

CONCENTRATIONS

6 Months Ended

Jun. 30, 2021

(8) CONCENTRATIONS

For the three months ended June 30, 2021, the Company sourced approximately 31% of the supplies for its electrotherapy products from one significant vendor (defined as supplying at least 10%). For the same period in 2020, the Company sourced approximately 36% of the supplies from one significant vendor.

For the six months ended June 30, 2021, the Company sourced approximately 35% of supplies for its electrotherapy products from two significant vendors. For the same period in 2020 the company sourced approximately 34% of supplies from one significant vendor.

Management believes that its relationships with suppliers are good; however, if the relationships were to be replaced, there may be a short-term disruption to operations, a period of time in which products may not be available and additional expenses may be incurred.

The Company had receivables from two third-party payers at June 30, 2021 that made up approximately 37% of the net accounts receivable balance. At December 31, 2020, the Company had receivables from one third-party payer that made up approximately 26% of the net accounts receivable balance.